These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 110917)

  • 21. Clonazepam in a focal-motor monkey model: efficacy, tolerance, toxicity, withdrawal, and management.
    Lockard JS; Levy RH; Congdon WC; DuCharme LL; Salonen LD
    Epilepsia; 1979 Dec; 20(6):683-95. PubMed ID: 115680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of clonazepam and its amino and acetamido metaoblites in human plasma by combined gas chromatography chemical ionization mass spectrometry and selected ion monitoring.
    Min BH; Garland WA; Khoo KC; Torres GS
    Biomed Mass Spectrom; 1978 Dec; 5(12):692-8. PubMed ID: 747743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.
    Sjö O; Hvidberg EF; Naestoft J; Lund M
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):249-54. PubMed ID: 1233220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of parent drug-metabolite relationship in the presence of an inducer. Application to the carbamazepine-clobazam interaction in normal man.
    Levy RH; Lane EA; Guyot M; Brachet-Liermain A; Cenraud B; Loiseau P
    Drug Metab Dispos; 1983; 11(4):286-92. PubMed ID: 6137332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
    Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
    Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of iosulamide in plasma and urine: application to intravenous pharmacokinetics in rhesus monkey.
    Park GB; Biddlecome CE; Rowe EA; Kullberg MP; Edelson J
    Drug Metab Dispos; 1981; 9(1):43-7. PubMed ID: 6111430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduction of clonazepam with enteric bacteria].
    Kuroiwa M; Inotsume N; Iwaoku R; Nakano M
    Yakugaku Zasshi; 1985 Oct; 105(10):960-5. PubMed ID: 4093858
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog.
    Kaplan SA; Alexander K; Jack ML; Puglisi CV; De Silva JA; Lee TL; Weinfeld RE
    J Pharm Sci; 1974 Apr; 63(4):527-32. PubMed ID: 4828698
    [No Abstract]   [Full Text] [Related]  

  • 31. An animal model for the study of drugs in the central nervous system.
    Parry GJ
    Proc Aust Assoc Neurol; 1976; 13():83-8. PubMed ID: 1029011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
    Woolf TF; Bjorge SM; Black AE; Holmes A; Chang T
    Drug Metab Dispos; 1991; 19(3):696-702. PubMed ID: 1680639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
    Chen IW; Lin JH
    Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic profile of progabide, a new gamma-aminobutyric acid-mimetic drug, in rhesus monkey.
    Johno I; Ludwick BT; Levy RH
    J Pharm Sci; 1982 Jun; 71(6):633-6. PubMed ID: 7097524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic disposition of guanabenz in the rhesus monkey.
    Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW
    Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol does not alter flutoprazepam kinetics and metabolism in the rat.
    Conti I; Sarati S; Caccia S
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):53-8. PubMed ID: 1936062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys.
    Zacchei AG; Dobrinska MR; Wishousky TI; Kwan KC; White SD
    Drug Metab Dispos; 1982; 10(1):20-7. PubMed ID: 6124378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactivation of eptaloprost in animals and man.
    Hildebrand M
    Prostaglandins; 1993 Aug; 46(2):177-89. PubMed ID: 7692471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.